Stocks in Play

Satellos Bioscience Inc.

11:02 AM EST - Satellos Bioscience Inc. : Announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation to SAT-3247 for the treatment of Duchenne. Satellos Bioscience Inc. shares T.MSCL are trading up $1.09 at $11.29.